PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabete
Cardiovascular risk reduction through obesity treatment is the entire point
However, if youre taking other diabetes medications, particularly insulin or sulfonylureas, the risk increases
Your First Month "*" indicates required fields By submitting this form, I consent to be contacted by Sant via phone, text, email, or mail
Theres no requirement or strong rationale to try Saxenda first
The development program of semaglutide 2.4 mg, STEP (Semaglutide Treatment Effect in People with obesity), consistently suggested an even greater BW lowering efficacy compared to SCALE 23